IP Library Assignment 030790/0047
Patent Assignment
Reel/Frame 030790/0047

Change of Name

Recorded: 2013-07-11 Pages: 2
Assignor
NEURON SYSTEMS, INC.
Executed: 2012-12-20
Assignee
ALDEXA THERAPEUTICS, INC.
15 NEW ENGLAND EXECUTIVE PARK, BURLINGTON, MASSACHUSETTS, 01803
Covered Property (1)
Compositions and Methods of Treating Retinal Disease
Patent: 7,973,025 →
Application: 11/441,848 →
Publication: US 2007/0135481
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 14, 2008
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 020655/0315 →
Change of Address of Assignee May 11, 2010
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 024367/0521 →
Security Agreement Apr 24, 2012
From: NEURON SYSTEMS, INC
To: SQUARE 1 BANK
Reel/Frame 028095/0947 →
Change of Name Aug 31, 2015
From: ALDEXA THERAPEUTICS, INC.
To: ALDEYRA THERAPEUTICS, INC.
Reel/Frame 036514/0946 →
Change of Name Sep 9, 2015
From: ALDEXA THERAPEUTICS, INC.
To: ALDEYRA THERAPEUTICS, INC.
Reel/Frame 036580/0033 →
Release of Security Interest Dec 5, 2018
From: PACIFIC WESTERN BANK (SUCCESSOR BY MERGER TO SQUARE 1 BANK)
To: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC. F/K/A NEURON SYSTEMS, INC.)
Reel/Frame 047683/0482 →